Susquehanna International Group’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-509
Closed -$29K 14128
2022
Q1
$29K Sell
509
-326
-39% -$19.7K ﹤0.01% 12520
2021
Q4
$56K Sell
835
-83
-9% -$7.21K ﹤0.01% 12491
2021
Q3
$94K Sell
918
-734
-44% -$78.4K ﹤0.01% 12105
2021
Q2
$188K Sell
1,652
-502
-23% -$58.2K ﹤0.01% 11659
2021
Q1
$267K Buy
2,154
+689
+47% +$96.3K ﹤0.01% 10845
2020
Q4
$149K Buy
1,465
+302
+26% +$35.6K ﹤0.01% 10258
2020
Q3
$193K Buy
+1,163
New +$241K ﹤0.01% 9484

Other funds holding QNTM

Susquehanna International Group's QNTM Position: Q3 2024 in Review

Susquehanna International Group sold out of Quantum Biopharma Class B Subordinate Voting Shares (QNTM) in Q3 2024, closing a stake of 430 shares — an estimated $4.47K sold.

Susquehanna International Group first reported a position in QNTM in Q3 2020 and held it in 16 quarters. The position peaked at $578K in Q1 2021. 12 funds tracked by Wall St. Rank hold QNTM as of Q3 2024.

  • Susquehanna International Group reported no remaining Quantum Biopharma Class B Subordinate Voting Shares position as of Q3 2024 after selling out during the quarter.
  • Susquehanna International Group sold 430 Quantum Biopharma Class B Subordinate Voting Shares shares in Q3 2024, an estimated $4.47K.
  • Susquehanna International Group first reported a position in Quantum Biopharma Class B Subordinate Voting Shares in Q3 2020 and held it in 16 quarters.
  • Susquehanna International Group's Quantum Biopharma Class B Subordinate Voting Shares position peaked at $578K in Q1 2021.
  • 12 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q3 2024.

Based on Susquehanna International Group's 13F filing for Q3 2024, filed 14 Nov 2024.